Related Experiment Video
Updated: Jul 30, 2026

09:07
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Brain protein metabolism in epilepsy.
Summary
Seizures severely inhibit brain protein synthesis by disrupting polyribosomes. This occurs even when systemic changes are controlled, suggesting direct effects on neuronal function and energy metabolism.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Generalized and focal seizures disrupt brain polyribosomes, inhibiting protein synthesis.
- This inhibition occurs independently of systemic changes like hypoxemia or hypoxia.
- Previous studies indicate focal inhibition of protein synthesis during seizures in animal models.
Purpose of the Study:
- To investigate the impact of seizures on brain protein synthesis.
- To explore the relationship between local cerebral blood flow, glucose metabolism, and protein synthesis inhibition during seizures.
- To elucidate the molecular mechanisms underlying translational regulation during seizures.
Main Methods:
- Autoradiography was used to study protein synthesis, glucose metabolism, and cerebral blood flow in animal models (rats and marmoset monkeys).
- Animals were subjected to generalized seizures, with some being artificially ventilated to control systemic factors.
- Analysis focused on the correlation between regional protein synthesis inhibition and the mismatch between local glucose metabolism and blood flow.
Main Results:
- Generalized seizures caused focal inhibition of brain protein synthesis.
- A significant mismatch between increased local glucose metabolism and limited increase in local cerebral blood flow was observed during seizures.
- Regions with the most severe protein synthesis inhibition showed the greatest mismatch between blood flow and metabolism.
- Evidence suggests that translational regulation, particularly at the initiation step, is involved, potentially via altered GDP/GTP ratios affecting ternary complex formation.
Conclusions:
- Seizures directly inhibit brain protein synthesis, with regional variations.
- The observed mismatch between cerebral metabolism and blood flow during seizures is linked to protein synthesis inhibition.
- Altered cellular energy charge, leading to increased GDP/GTP ratios, may inhibit protein synthesis initiation during seizures.
- Protein biosynthesis regulation during seizures is complex and likely involves multiple regulatory sites.
Related Concept Videos
Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

